ALS Investment Fund

ALS Investment Fund is an Amsterdam, Netherlands-based venture capital firm that invests in early-stage biotechnology companies developing therapies for amyotrophic lateral sclerosis and other neurodegenerative diseases. The firm bridges the funding gap between academic research and commercialization by deploying capital into high-risk clinical assets, having raised an initial fund of approximately €30 million from private investors and family offices. The organization is currently partnering with the ALS Association to raise a targeted $100 million for its second investment vehicle, ALS Investment Fund II.